CRP and coronary artery disorder: Recently, the platelet-to-lymphocyte ratio (PLR) has been researched as a predictor of CAD severity.1, 2 Easily required and relatively inexpensive, this efficient modality could help to predict the severity of CAD, in addition to conventional risk factors and commonly used biomarkers such as C-reactive protein (CRP).1